Clinical trial
Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy…
NCT00002192 · Anderson Clinical Research, Industry · Completed
Key facts
| NCT number | NCT00002192 |
|---|---|
| Title | Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia. |
| Official title | Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia. |
| Lead sponsor | Anderson Clinical Research, Industry |
| Collaborators | Hoechst Marion Roussel Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Mycobacterium Avium-Intracellulare Infection, HIV Infections |
| Intervention type | Drug |
| Interventions | Rifapentine, Ethambutol hydrochloride, Clarithromycin, Azithromycin |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: